These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 37207937)

  • 21. Plant Exosome-like Nanovesicles: Emerging Therapeutics and Drug Delivery Nanoplatforms.
    Dad HA; Gu TW; Zhu AQ; Huang LQ; Peng LH
    Mol Ther; 2021 Jan; 29(1):13-31. PubMed ID: 33278566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Techniques and Applications of Animal- and Plant-Derived Exosome-Based Drug Delivery System.
    Man F; Wang J; Lu R
    J Biomed Nanotechnol; 2020 Nov; 16(11):1543-1569. PubMed ID: 33461649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exosomal targeting and its potential clinical application.
    He J; Ren W; Wang W; Han W; Jiang L; Zhang D; Guo M
    Drug Deliv Transl Res; 2022 Oct; 12(10):2385-2402. PubMed ID: 34973131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Research status and challenges of plant-derived exosome-like nanoparticles.
    Bai C; Liu J; Zhang X; Li Y; Qin Q; Song H; Yuan C; Huang Z
    Biomed Pharmacother; 2024 May; 174():116543. PubMed ID: 38608523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engineered Exosomes: A Promising Drug Delivery Strategy for Brain Diseases.
    Jiang Y; Wang F; Wang K; Zhong Y; Wei X; Wang Q; Zhang H
    Curr Med Chem; 2022; 29(17):3111-3124. PubMed ID: 34477508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exosome engineering for efficient and targeted drug delivery: Current status and future perspective.
    Malekian F; Shamsian A; Kodam SP; Ullah M
    J Physiol; 2023 Nov; 601(22):4853-4872. PubMed ID: 35570717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson's disease treatment.
    Kojima R; Bojar D; Rizzi G; Hamri GC; El-Baba MD; Saxena P; Ausländer S; Tan KR; Fussenegger M
    Nat Commun; 2018 Apr; 9(1):1305. PubMed ID: 29610454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possibility of Exosome-Based Therapeutics and Challenges in Production of Exosomes Eligible for Therapeutic Application.
    Yamashita T; Takahashi Y; Takakura Y
    Biol Pharm Bull; 2018; 41(6):835-842. PubMed ID: 29863072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inside(sight) of tiny communicator: exosome biogenesis, secretion, and uptake.
    Jadli AS; Ballasy N; Edalat P; Patel VB
    Mol Cell Biochem; 2020 Apr; 467(1-2):77-94. PubMed ID: 32088833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications.
    Rahbarghazi R; Jabbari N; Sani NA; Asghari R; Salimi L; Kalashani SA; Feghhi M; Etemadi T; Akbariazar E; Mahmoudi M; Rezaie J
    Cell Commun Signal; 2019 Jul; 17(1):73. PubMed ID: 31291956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exosomes derived from lung cancer cells: Isolation, characterization, and stability studies.
    Ruzycka-Ayoush M; Nowicka AM; Kowalczyk A; Gluchowska A; Targonska A; Mosieniak G; Sobczak K; Donten M; Grudzinski IP
    Eur J Pharm Sci; 2023 Feb; 181():106369. PubMed ID: 36572357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The emerging role of exosomes as novel therapeutics: Biology, technologies, clinical applications, and the next.
    Song Y; Kim Y; Ha S; Sheller-Miller S; Yoo J; Choi C; Park CH
    Am J Reprod Immunol; 2021 Feb; 85(2):e13329. PubMed ID: 32846024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exosomes as natural delivery carriers for programmable therapeutic nucleic acid nanoparticles (NANPs).
    Ke W; Afonin KA
    Adv Drug Deliv Rev; 2021 Sep; 176():113835. PubMed ID: 34144087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exosome as a Novel Shuttle for Delivery of Therapeutics across Biological Barriers.
    Das CK; Jena BC; Banerjee I; Das S; Parekh A; Bhutia SK; Mandal M
    Mol Pharm; 2019 Jan; 16(1):24-40. PubMed ID: 30513203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of in vivo fate of exosomes for therapeutic applications: New frontier in nanomedicines.
    Park JH
    J Control Release; 2022 Aug; 348():483-488. PubMed ID: 35675897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Engineering exosomes as refined biological nanoplatforms for drug delivery.
    Luan X; Sansanaphongpricha K; Myers I; Chen H; Yuan H; Sun D
    Acta Pharmacol Sin; 2017 Jun; 38(6):754-763. PubMed ID: 28392567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exosomes as mediators of intercellular communication: clinical implications.
    Nazimek K; Bryniarski K; Santocki M; Ptak W
    Pol Arch Med Wewn; 2015; 125(5):370-80. PubMed ID: 25978300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coincident Fluorescence-Burst Analysis of the Loading Yields of Exosome-Mimetic Nanovesicles with Fluorescently-Labeled Cargo Molecules.
    Sanaee M; Sandberg E; Ronquist KG; Morrell JM; Widengren J; Gallo K
    Small; 2022 Mar; 18(12):e2106241. PubMed ID: 35084110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Engineered and Mimicked Extracellular Nanovesicles for Therapeutic Delivery.
    Poinsot V; Pizzinat N; Ong-Meang V
    Nanomaterials (Basel); 2024 Apr; 14(7):. PubMed ID: 38607173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemical Advances in Therapeutic Application of Exosomes and Liposomes.
    Chew BC; Liew FF; Tan HW; Chung I
    Curr Med Chem; 2022; 29(25):4445-4473. PubMed ID: 35189798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.